Stay updated on Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial

Sign up to get notified when there's something new on the Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Locations section now shows regional grouping under the Locations heading, adding regions such as Beijing Municipality, Guangdong, Hebei, Hunan, Jiangsu, Jilin, Liaoning, Shandong, Shanghai Municipality, Shanxi, and Sichuan. Corresponding city-level location entries (Beijing Municipality Locations, Guangdong Locations, etc.) were removed.
    Difference
    1%
    Check dated 2025-12-23T13:38:59.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.1 to v3.3.2. No visible changes to the study details or page content.
    Difference
    0.0%
    Check dated 2025-12-01T17:47:46.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page shows a new revision label, updating from v3.2.0 to v3.3.1. This appears to be a minor system update with no changes to the study details, eligibility, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T14:47:47.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    Removed the general funding-status notice about government funding and NIH operating status from the page. This removes guidance on updates about funding delays and where to check operating status.
    Difference
    0.3%
    Check dated 2025-11-17T06:55:02.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    Core study information remains unchanged between the two screenshots; there are no updates to the title, condition, interventions, outcomes, eligibility, enrollment, or locations. Only minor formatting/layout differences are observed.
    Difference
    0.3%
    Check dated 2025-11-03T01:17:47.000Z thumbnail image
  9. Check
    93 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    5%
    Check dated 2025-10-05T10:19:55.000Z thumbnail image

Stay in the know with updates to Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial page.